000 | 01138 a2200289 4500 | ||
---|---|---|---|
005 | 20250516221019.0 | ||
264 | 0 | _c20150528 | |
008 | 201505s 0 0 eng d | ||
022 | _a1537-6591 | ||
024 | 7 |
_a10.1093/cid/ciu471 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVan de Verg, Lillian L | |
245 | 0 | 0 |
_aEditorial commentary: a Shigella vaccine against prevalent serotypes. _h[electronic resource] |
260 |
_bClinical infectious diseases : an official publication of the Infectious Diseases Society of America _cOct 2014 |
||
300 |
_a942-3 p. _bdigital |
||
500 | _aPublication Type: Editorial; Comment | ||
650 | 0 | 4 |
_aDrug Discovery _xmethods |
650 | 0 | 4 |
_aDysentery, Bacillary _xepidemiology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aShigella _xclassification |
650 | 0 | 4 |
_aShigella Vaccines _ximmunology |
700 | 1 | _aVenkatesan, Malabi M | |
773 | 0 |
_tClinical infectious diseases : an official publication of the Infectious Diseases Society of America _gvol. 59 _gno. 7 _gp. 942-3 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/cid/ciu471 _zAvailable from publisher's website |
999 |
_c23946420 _d23946420 |